Following hip fracture, hospital organisational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study

Osteoporosis

Ten-year follow-up of fracture risk in a systematic population-based screening program: the risk-stratified osteoporosis strategy evaluation (ROSE) randomised trial

EClinicalMedicine

Petersen TG, Abrahamsen B, Høiberg M, Rothmann MJ, Holmberg T, Gram J, Bech M, Åkesson KE, Javaid MK, Hermann AP, Rubin KH

doi: 10.1016/j.eclinm.2024.102584

Osteoporosis

Long Dosing Intervals of Parenteral Antiosteoporosis Medications and the Decrease in Societal Fracture Risk: A 11-Year Nationwide Population-Based Cohort Study

Mayo Clin Proc

Fu SH, Yen HK, Yang RS, Hung CC, Lin JW, Lee MT, Chen HM, Wu CH, Hsu CC, Li CY, Groot OQ, Wang CY

doi: 10.1016/j.mayocp.2024.05.002

Rheumatoid Arthritis

Risk and predictors of fractures in early rheumatoid arthritis - A long term follow up study of an inception cohort

Semin Arthritis Rheum

Theander L, Sharma A, Karlsson MK, Åkesson KE, Jacobsson LTH, Turesson C

doi: 10.1016/j.semarthrit.2024.152497

Further Publications Rheumatology

Intensive physical activity following total hip arthroplasty increased the revision risk after 15 years: a cohort study of 973 patients from the Geneva Arthroplasty Register

Acta Orthop

Zaballa E, D'angelo S, Barea C, Ntani G, Hannouche D, Cooper C, Lübbeke A, Walker-Bone K

doi: 10.2340/17453674.2024.41192

Melanoma and Skin Cancer

St Andrews Referral Delay in Skin Cancer (StARDISC): A study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy

Br J Dermatol

Miranda BH, Shahid S, Correiro A, Zhang J, Kosasih S, El-Muttardi N

doi: 10.1093/bjd/ljaf097

Immunotherapy

Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study

Ann Oncol

Lordick F, Mauer ME, Stocker G, Cella CA, Ben-Aharon I, Piessen G, Wyrwicz L, Al-Haidari G, Fleitas-Kanonnikoff T, Boige V, Obermannová RL, Martens UM, Gomez-Martin C, Thuss-Patience P, Arrazubi V, Avallone A, Shiu KK, Artru P, Brenner B, Sanchez CB, Chau I, Lorenzen S, Daum S, Sinn M, Merelli B, van Grieken NCT, Nilsson M, Collienne M, Giraut A, Smyth E

doi: 10.1016/j.annonc.2024.10.829

Further Publications Dermatology

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

Lancet

GBD 2021 Risk Factors Collaborators

doi: 10.1016/S0140-6736(24)00933-4

Systemic Lupus Erythematosus

Cutaneous vasculitis in systemic lupus erythematosus: epidemiology and risk factors over a 20-year follow-up

Rheumatology (Oxford)

Saleh A, Yee CS, Acquah A, Gordon C, Reynolds JA

doi: 10.1093/rheumatology/keae672